| 证券代码：300791 | 证券简称：仙乐健康 公告编码：2025-095 | | --- | --- | | 债券代码：123113 | 债券简称：仙乐转债 | 仙乐健康科技股份有限公司 关于部分董事、高级管理人员减持股份计划期限届满 公司董事杨睿女士保证向本公司提供的信息真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 仙乐健康科技股份有限公司（以下简称"公司"或"仙乐健康"）于 2025 年 7 月 3 日披露了《关于部分董事、高级管理人员减持股份计划的提示性公告》 （公告编码：2025-063），公司董事、副总经理姚壮民先生计划在 2025 年 7 月 25 日至 2025 年 10 月 24 日期间以大宗交易或集中竞价方式减持公司股份不超过 2,019,489 股（约占公司总股本 0.66%），公司董事杨睿女士计划在 2025 年 7 月 25 日至 2025 年 10 月 24 日期间以大宗交易或集中竞价方式减持公司股份不超过 2,481,491 股（约占公司总股本 0.81%）。 公司于近日收到公司董事、副总经理姚 ...

格隆汇10月23日丨仙乐健康(300791.SZ)在互动平台表示，公司业务暂无涉及人造肉领域。 ...

每经AI快讯，有投资者在投资者互动平台提问：请问公司是否有涉及人造肉领域？ 仙乐健康（300791.SZ）10月23日在投资者互动平台表示，公司业务暂无涉及人造肉领域。 （记者 王瀚黎） ...

Core Insights - The food processing sector experienced a slight increase of 0.04% on October 22, with *ST Chuntian leading the gains [1] - The Shanghai Composite Index closed at 3913.76, down 0.07%, while the Shenzhen Component Index closed at 12996.61, down 0.62% [1] Stock Performance - *ST Chuntian (600381) closed at 5.45, up 5.01% with a trading volume of 97,100 shares and a turnover of 52.64 million yuan [1] - Other notable gainers included Jinzi Ham (002515) up 1.91%, Xiwang Food (000639) up 1.27%, and Delisi (002330) up 1.23% [1] - Conversely, Baba Food (605338) saw a decline of 2.72%, while Jiaoda Onl (600530) fell by 2.41% [2] Capital Flow - The food processing sector saw a net outflow of 87.36 million yuan from institutional investors, while retail investors contributed a net inflow of 124 million yuan [2] - The main stocks with significant capital flow included *ST Chuntian, which had a net inflow of 14.16 million yuan from institutional investors [3] - Other stocks like Guangming Meat (600073) and Jindawei (002626) also experienced varying degrees of net inflow and outflow from different investor categories [3]

Investment Rating - The report maintains a recommendation for the liquor sector, indicating a bottoming out phase with potential for recovery in the future [2]. Core Insights - The liquor industry is experiencing a significant decline in sales, with an expected drop of over 20% in overall sales volume. However, there are signs of month-on-month improvement, and the decline is narrowing [5][9]. - Major liquor companies like Moutai and Wuliangye are showing strong recovery in payment collection, with over 80% collection rates, while regional brands are performing adequately [5][9]. - The report emphasizes the importance of focusing on high-quality liquor brands that are likely to recover faster, such as Moutai and Fenjiu, while also highlighting the need to monitor companies undergoing significant changes [6][9]. Summary by Sections 1. Liquor Sector: Q3 Accelerated Decline and Bottoming Out - The liquor sector is facing a 20%+ decline in sales due to external demand shocks, with a gradual improvement expected in the coming months [5][9]. - High-end liquor brands are expected to show resilience, with Moutai projected to achieve a 3% revenue growth in Q3, while Wuliangye is expected to see a 20% revenue decline [10][11]. - The report indicates that companies are adjusting their strategies to reduce channel pressure and improve operational efficiency [9][10]. 2. Consumer Goods Sector: Overall Demand Weakness, Structural Resilience - The consumer goods sector is experiencing overall weak demand, but segments like snacks and beverages are showing higher resilience [17][24]. - The report notes that while the demand for dairy and beer remains stable, the restaurant supply chain is still under pressure [17][24]. - Raw material prices are generally declining, which may provide some cost relief to companies in the sector [24][25]. 3. Investment Recommendations: Focus on Liquor Bottoming Catalysts and Selective Consumer Goods Trends - The report suggests focusing on liquor companies that are at the bottom of their cycles, with Moutai and Fenjiu being primary recommendations [6][9]. - For consumer goods, the report highlights the potential of snack and beverage companies, recommending brands that are well-positioned to benefit from current trends [6][17].

[Table_Title] 保健品行业产业链和重点企业解析 [Table_ReportType] ——保健品行业专题系列一[Table_ReportDate] [行业核心观点： Table_Summary] 2020-2024年间，我国保健品行业市场规模从3213.7亿元增长至4150.3 亿元，年均复合增长率达到6.60%，已成为仅次于美国的全球第二大保 健品市场。人均消费方面，我国人均保健品消费金额仅约为海外成熟市 场如澳大利亚/韩国/美国的1/5左右；渗透率方面，我国保健品市场消 费人群渗透率普遍偏低，其中65岁以上老年群体作为保健品主要消费 群体，渗透率仅为23.04%，而美国为73.04%，我国存在2-3倍的增长空 间。产业链方面，上游原料多样，多数赛道产能集中；中下游企业盈利 能力相对较强，加速海外布局；终端销售电商增长强劲，传统渠道承压。 随着监管完善，以及渠道、需求、供给的有效驱动，预计中长期我国保 健品行业仍将保持增长趋势，中下游代工与品牌盈利能力相对较强，建 议重点关注在产业链中下游积极布局，且渠道、研发实力较强的保健 品龙头企业。 投资要点： ⚫ 行业：预计中长期我国保健品行业仍将保持增 ...

近日，一则由智通财经刊发的调查报道，将直播带货领域的顶流主播"清华冯博士"推上舆论的风口浪 尖。 "专利防蓝光配比"、"让孩子学得多记得牢"、"1粒补2样，眼脑双效补充......"一款名为养能健"学龄DHA 藻油叶黄素酯凝胶糖果"的产品在抖音平台热销，在抖音商城爆款榜单一度排名第一。 达人主播"清华冯博士-儿童营养研发专家"及其助播每日7：30在其直播间准时开播重复讲解、主推这款 产品，并同时在微信视频号、快手等平台开设账号进行宣传。 事件的核心，是一位拥有清华大学博士光环背书的知识型主播，和一款宣称能"补眼脑""防蓝光""让孩 子学得多记得牢"的"神奇糖果"。 在短短数月内，这款产品及其背后的品牌"养能健"创造了令人咋舌的销售奇迹，一度登顶短视频平台商 城爆款榜首位。 随后，13日，福建省厦门市集美区市场监督管理局已介入调查。 经查，报道所涉产品"养能健学龄DHA藻油叶黄素酯凝胶糖果"的委托生产方为厦门养能健璟生物科技 有限公司，受委托生产方为广东汕头仙乐健康科技股份有限公司。 厦门养能健璟生物科技有限公司通过抖音直播间"清华冯博士-儿童营养研发专家"销售涉事产品。 检查发现，该直播间涉嫌虚假宣传的违法行 ...

Investment Rating - The report maintains a "Recommended" rating for the food and beverage industry [1] Core Views - The overall sales of liquor during the recent double festival are weak, with a year-on-year decline of 20%-30%, aligning with previous expectations. High-end brands like Moutai and Wuliangye performed relatively well, while lower-tier brands faced significant pressure [5] - The price stability of liquor during the double festival is noted, with slight increases observed post-festival. The report suggests monitoring price trends as e-commerce promotions begin [5] - The upcoming Sugar and Wine Conference is expected to provide marginal feedback, with the industry showing signs of bottoming out. The report emphasizes the importance of this event for potential recovery opportunities [6][7] Summary by Sections Recent Trends - The food and beverage sector has underperformed the Shanghai Composite Index, with a 0.61% increase compared to the index's 1.80% rise over the past two weeks [14] - The soft drink segment saw the highest increase of 9.98%, while several companies like Zhuangyuan Pasture and Yangyuan Beverage led the gains [14] Key Companies and Earnings Forecast - The report highlights several key companies with their respective earnings per share (EPS) and price-to-earnings (PE) ratios, recommending stocks such as Kweichow Moutai, Wuliangye, and Luzhou Laojiao for investment [25] - The report provides a detailed table of key companies, their stock prices, and projected earnings for 2024, 2025, and 2026, indicating a bullish outlook for several firms [25] Investment Strategy - The report suggests that recent policy changes may improve macroeconomic expectations, potentially enhancing both valuation and performance in the food and beverage sector. The overall valuation remains low, justifying the "Recommended" rating [8][23] - Specific recommendations include high-end liquor brands and popular consumer goods, indicating a diversified investment strategy across different segments of the food and beverage industry [8][23]

Investment Rating - The industry investment rating is "Positive" (maintained) [2] Core Insights - The report highlights structural growth opportunities in new products and channels within the consumer goods sector, particularly in the context of the 25Q3 performance forecast [2] - The performance of various sub-sectors is expected to vary, with specific companies showing significant growth potential due to category advantages and new channel expansions [10][12][14][15][16][19][21][22] Sub-sector Summaries 1.1 Snack Foods - The performance in 25Q3 is expected to be differentiated, with companies like Wanchen Group projected to achieve a revenue growth of 39% and a net profit growth of 382% [2][25] - Emphasis is placed on companies that can leverage category trends and new channel opportunities for sustained growth [10][11] 1.2 Soft Drinks - The energy drink segment is showing improved market conditions, with companies like Dongpeng Beverage expected to see a revenue growth of 31% and a net profit growth of 33% [2][25] - The report suggests focusing on companies with strong brand power and channel capabilities for long-term growth [12][13] 1.3 Dairy Products - The dairy sector is anticipated to experience flat demand in 25Q3, with companies like Yili expected to see only a 2% revenue growth [2][25] - The report indicates that profitability may improve once raw milk prices stabilize [14] 1.4 Tea Drinks - The market is characterized by a leading player, Mixue Group, which is expected to expand its competitive edge through enhanced product offerings [2][15] - The mid-price segment is highlighted as a key growth area, with recommendations for companies like Guming [15] 1.5 Health Supplements - The report notes a trend towards increased concentration in the B-end market, with companies like Xianle Health projected to achieve a revenue growth of 15% [2][25] - The C-end market is advised to focus on high-growth single products [16][17] 1.6 Ready-to-Drink Alcohol - The performance in 25Q3 is expected to be strong, with companies like Bairun expected to see an 8% revenue growth [2][25] - New product launches are anticipated to drive sales growth [18] 1.7 Beer - The impact of the "drinking ban" is expected to be limited, with Qingdao Beer projected to achieve a 2% revenue growth and an 8% net profit growth [2][25] - The report suggests that the beer sector will see stable growth driven by structural upgrades and cost improvements [19][20] 1.8 Condiments - Leading companies like Haitian Flavoring are expected to maintain stable performance, with a revenue growth of 7% [2][25] - The report emphasizes the importance of robust market strategies during periods of flat demand [21] 1.9 Frozen Foods - The sector is facing weak demand, with companies like Anjixin expected to see a 6% revenue growth [2][25] - The report advises monitoring the recovery of the restaurant supply chain for potential investment opportunities [22][23] 1.10 Marinated Products - The focus is on improving store operations as the sector continues to recover from previous challenges [24] Key Company Tracking - The report provides a detailed forecast for various companies across different segments, highlighting expected revenue and net profit growth rates for 25Q3 [25]

每经AI快讯，仙乐健康（SZ 300791，收盘价：23.33元）10月9日晚间发布公告称，仙乐健康科技股份 有限公司及公司子公司在2025年第三季度取得4项发明专利证书、1项保健食品注册证书和22项保健食品 备案凭证。 截至发稿，仙乐健康市值为72亿元。 每经头条（nbdtoutiao）——与美元脱钩后，暴涨102倍，揭秘黄金疯涨背后神秘的"无形之手"！专家： 推动金价上涨的逻辑没有变 （记者 曾健辉） 2025年1至6月份，仙乐健康的营业收入构成为：软胶囊占比46.38%，软糖占比25.31%，片剂占比 9.26%，功能饮品占比5.42%，硬胶囊占比5.31%。 ...